{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:30:01Z","timestamp":1671784201069},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of our study was to evaluate high-density lipoprotein cholesterol (HDL-C) efflux capacity in healthy controls and patients with severe dyslipidemia. Evaluation of HDL function may be beneficial for better understanding of cardiovascular diseases, as well as for taking actions to minimize residual cardiovascular risk.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>During 2016\u20132017 a total of 93 participants \u2013 48 (51.6%) women and 45 (48.4%) men \u2013 were included in this cross-sectional study. Data of 45 (48.4%) participants with severe dyslipidemia (SD) and 48 (51.6%) controls without dyslipidemia was used for statistical analysis. Total lipid panel, concentration of lipoprotein (a) and apolipoproteins were measured, data about cardiovascular risk factors were collected and detailed evaluation of HDL-C quality was performed for all patients.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Increased HDL-C concentration was associated with higher ApoA1 (<jats:italic>r<\/jats:italic>\u2009=\u20090.866 in controls, <jats:italic>r<\/jats:italic>\u2009=\u20090.63 in SD group), ApoA2 (<jats:italic>r<\/jats:italic>\u2009=\u20090.41 in controls, <jats:italic>r<\/jats:italic>\u2009=\u20090.418 in SD group) and LDL-C concentrations (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.412 in SD group), lower ApoE (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.314 in SD group) and TG concentrations (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.38 in controls, <jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.608 in SD group), lower ApoB\/ApoA1 ratio (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.567 in control group), below average HDL-C efflux capacity (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.335 in SD group), lower BMI (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.327 in controls, <jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.531 in SD group) and abdominal circumference (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.309 in women with SD). Below-average HDL-C efflux capacity was found in 67.7% (<jats:italic>N<\/jats:italic>\u2009=\u200963) of participants. It was more often found among patients with normal weight or BMI 30\u201331\u2009kg\/m2. HDL-C efflux capacity was inversely associated with HDL-C concentration (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.228).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Abnormal HDL function may be associated with residual cardiovascular risk in Lithuanian population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-019-1124-2","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T09:03:52Z","timestamp":1572080632000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lower than average HDL cholesterol efflux capacity in Lithuanian population"],"prefix":"10.1186","volume":"18","author":[{"given":"Sandra","family":"Kutkiene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaneta","family":"Petrulioniene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dovile","family":"Karciauskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandras","family":"Laucevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabija","family":"Matuzevicien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justina","family":"Staigyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akvil\u0117 Saulyte","family":"Mikulskiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urte","family":"Gargalskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egle","family":"Skiauteryte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milda","family":"Kovaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,26]]},"reference":[{"key":"1124_CR1","unstructured":"Country Health Profiles - Public Health - European Commission [Internet]. Public Health. [cited 2018 Oct 27]. Available from: \n                    https:\/\/ec.europa.eu\/health\/sites\/health\/files\/state\/docs\/chp_lt_english.pdf\n                    \n                  ."},{"key":"1124_CR2","unstructured":"EUROSTAT Cardiovascular diseases statistics [Internet]. Available from: \n                    https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php\/Cardiovascular_diseases_statistics#Deaths_from_cardiovascular_diseases\n                    \n                  ."},{"key":"1124_CR3","unstructured":"The prevalence of dislipidemia and its relation to other risk factors: a nationwide survey of Lithuania | Request PDF [Internet]. ResearchGate. [cited 2018 Oct 27]. Available from: \n                    https:\/\/www.researchgate.net\/publication\/282001927_The_prevalence_of_dislipidemia_and_its_relation_to_other_risk_factors_a_nationwide_survey_of_Lithuania\n                    \n                  ."},{"key":"1124_CR4","doi-asserted-by":"crossref","unstructured":"Kutkiene S, Petrulioniene Z, Laucevicius A, Serpytis P, Kasiulevicius V, Staigyte J, et al. Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009\u20132016 in Lithuania. Lipids Health Dis [Internet]. 2018 Oct 11 [cited 2018 Nov 28];17. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6180581\/\n                    \n                  .","DOI":"10.1186\/s12944-018-0883-5"},{"key":"1124_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-60761-424-1_12","volume":"1","author":"JS Lilley","year":"2015","unstructured":"Lilley JS, Linton MF, Fazio S. Genetic disorders of HDL metabolism. Contemp Endocrinol. 2015;1:221\u201333.","journal-title":"Contemp Endocrinol"},{"issue":"3","key":"1124_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cjca.2016.09.012","volume":"33","author":"HY Choi","year":"2017","unstructured":"Choi HY, Hafiane A, Schwertani A, Genest J. High-density lipoproteins: biology, epidemiology, and clinical management. Can J Cardiol. 2017;33(3):325\u201333.","journal-title":"Can J Cardiol"},{"issue":"9602","key":"1124_CR7","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","volume":"370","author":"S Lewington","year":"2007","unstructured":"Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet Lond Engl. 2007;370(9602):1829\u201339.","journal-title":"Lancet Lond Engl"},{"issue":"18","key":"1124_CR8","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","volume":"302","author":"E Di Angelantonio","year":"2009","unstructured":"Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993\u20132000.","journal-title":"JAMA."},{"issue":"3","key":"1124_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrd1658","volume":"4","author":"P Linsel-Nitschke","year":"2005","unstructured":"Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov. 2005;4(3):193\u2013205.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1124_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.115.011646","volume":"133","author":"LD Colantonio","year":"2016","unstructured":"Colantonio LD, Bittner V, Reynolds K, Levitan EB, Rosenson RS, Banach M, et al. Association of Serum Lipids and Coronary Heart Disease in contemporary observational studies. Circulation. 2016;133(3):256\u201364.","journal-title":"Circulation."},{"issue":"9841","key":"1124_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","volume":"380","author":"BF Voight","year":"2012","unstructured":"Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572\u201380.","journal-title":"Lancet"},{"key":"1124_CR12","doi-asserted-by":"publisher","first-page":"g4379","DOI":"10.1136\/bmj.g4379","volume":"349","author":"D Keene","year":"2014","unstructured":"Keene D, Price C, Shun-Shin MJ, Francis DP. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients. BMJ. 2014;349:g4379.","journal-title":"BMJ."},{"issue":"3","key":"1124_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.beem.2013.11.002","volume":"28","author":"PP Toth","year":"2014","unstructured":"Toth PP, Barylski M, Nikolic D, Rizzo M, Montalto G, Banach M. Should low high-density lipoprotein cholesterol (HDL-C) be treated? Best Pract Res Clin Endocrinol Metab. 2014;28(3):353\u201368.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"1124_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.plipres.2012.03.003","volume":"51","author":"A Otocka-Kmiecik","year":"2012","unstructured":"Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ, Davidson M, Rysz J, Banach M. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res. 2012;51(4):314\u201324.","journal-title":"Prog Lipid Res"},{"issue":"32","key":"1124_CR15","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","volume":"38","author":"CM Madsen","year":"2017","unstructured":"Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38(32):2478\u201386.","journal-title":"Eur Heart J"},{"issue":"4","key":"1124_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011;8(4):222\u201332.","journal-title":"Nat Rev Cardiol"},{"issue":"Supplement","key":"1124_CR17","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","volume":"50","author":"DJ Rader","year":"2009","unstructured":"Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res. 2009;50(Supplement):S189\u201394.","journal-title":"J Lipid Res"},{"issue":"7","key":"1124_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","volume":"3","author":"D Saleheen","year":"2015","unstructured":"Saleheen D, Scott R, Javad S, Zhao W, Rodrigues A, Picataggi A, et al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol. 2015 Jul;3(7):507\u201313.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"25","key":"1124_CR19","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"issue":"3","key":"1124_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5603\/KP.2016.0029","volume":"74","author":"T Zdrojewski","year":"2016","unstructured":"Zdrojewski T, Solnica B, Cybulska B, Bandosz P, Rutkowski M, Stokwiszewski J, et al. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiol Pol. 2016;74(3):213\u201323.","journal-title":"Kardiol Pol"},{"issue":"1","key":"1124_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12944-018-0851-0","volume":"17","author":"S Kutkiene","year":"2018","unstructured":"Kutkiene S, Petrulioniene Z, Laucevicius A, Matuzeviciene G, Kasiulevicius V, Petrulionyte E, et al. Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population. Lipids Health Dis. 2018;17(1):208.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1124_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cvr\/cvy198","volume":"115","author":"P Penson","year":"2019","unstructured":"Penson P, Long DL, Howard G, Howard VJ, Jones SR, Martin SS, et al. Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for geographical and racial differences in stroke (REGARDS) study. Cardiovasc Res. 2019;115(1):204\u201312.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1124_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","volume":"7","author":"PP Toth","year":"2013","unstructured":"Toth PP, Barter PJ, Rosenson RS, Boden WE, Chapman MJ, Cuchel M, et al. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7(5):484\u2013525.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"1124_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.atherosclerosis.2009.02.041","volume":"206","author":"MT Cooney","year":"2009","unstructured":"Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, et al. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis. 2009;206(2):611\u20136.","journal-title":"Atherosclerosis."},{"key":"1124_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ijcard.2018.11.095","volume":"276","author":"M Mazidi","year":"2019","unstructured":"Mazidi M, Mikhailidis DP, Banach M. Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults. Int J Cardiol. 2019;276:242\u20137.","journal-title":"Int J Cardiol"},{"issue":"5","key":"1124_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1123\/jpah.2015-0378","volume":"13","author":"E Mertens","year":"2016","unstructured":"Mertens E, Clarys P, Lefevre J, Charlier R, Knaeps S, Deforche B. Longitudinal study on the association between cardiorespiratory fitness, anthropometric parameters and blood lipids. J Phys Act Health. 2016;13(5):467\u201373.","journal-title":"J Phys Act Health"},{"issue":"12","key":"1124_CR27","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1210\/jc.2017-00851","volume":"102","author":"DL Demmer","year":"2017","unstructured":"Demmer DL, Beilin LJ, Hands B, Burrows S, Cox KL, Oddy WH, et al. Fatness and Fitness With Cardiometabolic Risk Factors in Adolescents. J Clin Endocrinol Metab. 2017;102(12):4467\u201376.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1124_CR28","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.jacl.2016.09.008","volume":"10","author":"GL Vega","year":"2016","unstructured":"Vega GL, Grundy SM, Barlow CE, Leonard D, Willis BL, DeFina LF, et al. Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men. J Clin Lipidol. 2016;10(6):1414\u201322 e1.","journal-title":"J Clin Lipidol"},{"issue":"9","key":"1124_CR29","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/ATVBAHA.108.181438","volume":"29","author":"M Walter","year":"2009","unstructured":"Walter M. Interrelationships among HDL metabolism, aging, and atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29(9):1244\u201350.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1124_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0002-9343(87)90272-5","volume":"82","author":"RA Kreisberg","year":"1987","unstructured":"Kreisberg RA, Kasim S. Cholesterol metabolism and aging. Am J Med. 1987;82(1):54\u201360.","journal-title":"Am J Med"},{"key":"1124_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cca.2015.10.021","volume":"452","author":"S Arora","year":"2016","unstructured":"Arora S, Patra SK, Saini R. HDL-A molecule with a multi-faceted role in coronary artery disease. Clin Chim Acta Int J Clin Chem. 2016;452:66\u201381.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"7","key":"1124_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1440-1681.2010.05380.x","volume":"37","author":"EA Podrez","year":"2010","unstructured":"Podrez EA. Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol. 2010;37(7):719\u201325.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"9","key":"1124_CR33","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1161\/01.ATV.0000175760.28378.80","volume":"25","author":"N Rotllan","year":"2005","unstructured":"Rotllan N, Ribas V, Calpe-Berdiel L, Mart\u00edn-Campos JM, Blanco-Vaca F, Escol\u00e0-Gil JC. Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol. 2005;25(9):e128\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"25","key":"1124_CR34","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371(25):2383\u201393.","journal-title":"N Engl J Med"},{"issue":"6","key":"1124_CR35","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1161\/ATVBAHA.115.305504","volume":"35","author":"AP Agarwala","year":"2015","unstructured":"Agarwala AP, Rodrigues A, Risman M, McCoy M, Trindade K, Qu L, et al. High-density lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease. Arterioscler Thromb Vasc Biol. 2015;35(6):1515\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-1124-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T23:13:21Z","timestamp":1603581201000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-1124-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,26]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-1124-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,26]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study was approved of the Local Research Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from each author, and there are no other persons who satisfy the criteria for authorship but are not listed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}